Total Payments
$4,062
2024 Payments
$293.24
Companies
26
Transactions
201
Medicare Patients
11,756
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$4,036 (99.4%)
Education$25.99 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,036 | 197 | 99.4% |
| Education | $25.99 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $644.99 | 28 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $579.91 | 33 | $0 (2024) |
| Amgen Inc. | $492.21 | 20 | $0 (2024) |
| Gilead Sciences, Inc. | $277.20 | 15 | $0 (2018) |
| Lantheus Medical Imaging, Inc. | $241.71 | 13 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $239.32 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $181.20 | 9 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168.17 | 8 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $167.37 | 9 | $0 (2018) |
| PFIZER INC. | $162.30 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.24 | 12 | Kiniksa Pharmaceuticals International, plc ($55.38) |
| 2023 | $90.81 | 4 | Janssen Pharmaceuticals, Inc ($59.16) |
| 2022 | $236.09 | 10 | Janssen Pharmaceuticals, Inc ($92.73) |
| 2021 | $446.95 | 19 | Esperion Therapeutics, Inc. ($90.36) |
| 2020 | $178.86 | 9 | PFIZER INC. ($42.63) |
| 2019 | $594.74 | 29 | Janssen Pharmaceuticals, Inc ($148.68) |
| 2018 | $1,372 | 73 | Novartis Pharmaceuticals Corporation ($216.90) |
| 2017 | $849.04 | 45 | Novartis Pharmaceuticals Corporation ($182.77) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $20.76 | General |
| 10/24/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Not Applicable | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.83 | General |
| 09/06/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/25/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiology | ||||||
| 06/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Not Applicable | ||||||
| 03/26/2024 | Terumo Medical Corporation | GLIDEWIRE (Device) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: LESION ACCESS | ||||||
| 04/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/16/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/21/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Cardiology | ||||||
| 07/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Cardiovascular | ||||||
| 06/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: DIABETES | ||||||
| 02/10/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,801 | 4,050 | $1.0M | $250,965 |
| 2022 | 39 | 2,904 | 4,122 | $1.0M | $269,043 |
| 2021 | 40 | 3,328 | 4,650 | $1.2M | $328,889 |
| 2020 | 32 | 2,723 | 3,904 | $882,842 | $229,879 |
Total Patients
11,756
Total Services
16,726
Medicare Billing
$1.1M
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 308 | 449 | $231,542 | $64,665 | 27.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 108 | 108 | $161,856 | $42,363 | 26.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 244 | 245 | $166,659 | $31,492 | 18.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 109 | 218 | $82,606 | $20,825 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 166 | $60,875 | $16,545 | 27.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 66 | 264 | $29,905 | $11,195 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $28,712 | $8,018 | 27.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 447 | 638 | $33,472 | $7,738 | 23.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 126 | 127 | $30,100 | $6,915 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 58 | $17,527 | $5,844 | 33.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 663 | 877 | $24,556 | $5,783 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $20,906 | $4,652 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $12,429 | $4,005 | 32.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 38 | $15,190 | $3,888 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 49 | $10,267 | $3,149 | 30.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 26 | 28 | $13,333 | $2,483 | 18.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 37 | 37 | $23,521 | $2,136 | 9.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $11,502 | $1,250 | 10.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 13 | 13 | $4,495 | $1,224 | 27.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 69 | $4,868 | $1,207 | 24.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 24 | 234 | $2,483 | $982.80 | 39.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 50 | 50 | $4,013 | $979.77 | 24.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 21 | 95 | $3,800 | $951.90 | 25.1% |
| 93784 | Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | Office | 2023 | 20 | 20 | $3,517 | $756.37 | 21.5% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 42 | 42 | $2,054 | $459.38 | 22.4% |
About Dr. Eric Davidson, MD
Dr. Eric Davidson, MD is a Cardiovascular Disease healthcare provider based in Framingham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669437513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Davidson, MD has received a total of $4,062 in payments from pharmaceutical and medical device companies, with $293.24 received in 2024. These payments were reported across 201 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,036).
As a Medicare-enrolled provider, Davidson has provided services to 11,756 Medicare beneficiaries, totaling 16,726 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Framingham, MA
- Active Since 04/20/2006
- Last Updated 08/16/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669437513
Products in Payments
- XARELTO (Drug) $644.99
- ENTRESTO (Drug) $565.67
- Repatha (Biological) $275.27
- ELIQUIS (Drug) $259.91
- Corlanor (Drug) $196.18
- BRILINTA (Drug) $191.88
- Definity (Drug) $157.89
- PRALUENT (Drug) $135.53
- NEXLETOL (Drug) $108.73
- PRADAXA (Drug) $105.92
- LifeVest (Device) $91.15
- DEFINITY (Drug) $83.82
- CHANTIX (Drug) $83.59
- Vascepa (Drug) $75.56
- PRALUENT (Biological) $68.91
- KENGREAL (Drug) $62.50
- JARDIANCE (Drug) $62.25
- PRALUENT ALIROCUMAB INJECTION (Biological) $57.52
- Arcalyst (Drug) $55.38
- ONPATTRO (Drug) $53.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Framingham
Dr. Christopher Gange, Md, MD
Cardiovascular Disease — Payments: $7,509
Cardiovascular Disease $7,509
Dr. Patrick Blomberg, Md, MD
Cardiovascular Disease — Payments: $6,797
Cardiovascular Disease $6,797
Dr. James Alderman, Md, MD
Cardiovascular Disease — Payments: $5,212
Cardiovascular Disease $5,212
Dr. Donald Love, Md, MD
Cardiovascular Disease — Payments: $3,562
Cardiovascular Disease $3,562
George Kinzfogl, Md, MD
Cardiovascular Disease — Payments: $2,609
Cardiovascular Disease $2,609
Vikas Desai, Md, MD
Cardiovascular Disease — Payments: $2,145
Cardiovascular Disease $2,145